HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for better calcium control in rare hormone disorder
Disease control Not yet recruitingThis Phase 3 trial is testing whether higher daily doses of an investigational long-acting parathyroid hormone drug (palopegteriparatide) are safe and more effective for adults with hypoparathyroidism. The study aims to help participants maintain normal blood calcium levels while…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New survey aims to give greek patients a voice in their care
Knowledge-focused Not yet recruitingThis study aims to translate and validate a patient questionnaire about symptoms and quality of life for use with Greek-speaking people who have hypoparathyroidism. Researchers will work with 200 adult patients who are already on standard treatment for this chronic condition. The…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC
-
Moms on thyroid drug help science: is medicine in their milk?
Knowledge-focused Not yet recruitingThis study aims to find out if a medication called palopegteriparatide (YORVIPATH), used to treat a rare hormone condition, passes into breast milk. It will observe 10 breastfeeding women who are already taking this drug as part of their regular care. Researchers will collect and…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Ascendis Pharma A/S • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC